Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

UB 621

Next Previous
X
Search
Drug Profile

UB 621

Alternative Names: UB-621

Latest Information Update: 28 Oct 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator United BioPharma
  • Class Antivirals; Monoclonal antibodies; Skin disorder therapies
  • Mechanism of Action Immunomodulators; Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Herpes simplex virus infections

Most Recent Events

  • 28 Oct 2023 No recent reports of development identified for phase-I development in Herpes-simplex-virus-infections(In volunteers) in Taiwan (SC, Injection)
  • 18 Oct 2021 UB 621 is still in phase I trials for Herpes simplex virus infections in Taiwan
  • 18 Oct 2021 United Biopharma partners with the Shanghai Public Health Clinical Centre and National Cheng Kung University to test efficacy of UB 621 for the treatment of Herpes simplex virus infections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top